Welcome to the e-CCO Library!

search
Search by: 
Year: Category: Sub Type:
DOP056: Pathophysiology of perianal Fistulising Disease
Year: 2017
Source: ECCO'17 Barcelona
Authors: Scharl M.
Perianal disease
Files: 1
DOP056: Pharmacokinetics and Exposure-Response Relationships of Golimumab in Pediatric Patients with Moderate to Severe Ulcerative Colitis: Results from a Multicenter Open Label Study
Year: 2016
Source: ECCO'16 DOP
Authors: Adedokun O.
Ulcerative Colitis, Therapeutic drug monitoring, golimumab
Files: 1
DOP057: Perianal pediatric Crohn's Disease is associated with a distinct phenotype and greater inflammatory burden
Year: 2017
Source: ECCO'17 Barcelona
Authors: Assa A.
Crohn's disease, Disease activity Indices, Perianal fistulae, Perianal disease
Files: 1
DOP057: Tailored step-up approach results in beneficial long-term disease outcome in the prospective Belgian registry of paediatric Crohn’s disease (BELCRO)
Year: 2016
Source: ECCO'16 DOP
Authors: Wauters L.
anti-TNF agents, Crohn's Disease, thiopurines (AZA/MP)
Files: 1
DOP058: Combined stem cells and anticytokine therapy contributes to a more pronounced decrease in the degree of inflammation of the intestinal mucosa in Crohn's Disease
Year: 2018
Source: ECCO'18 Vienna
Authors: Kagramanova Anna
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP058: Does biologic therapy increase the risk for fistula-associated mucinous adenocarcinoma in long standing perianal Crohn’s Disease?
Year: 2017
Source: ECCO'17 Barcelona
Authors: Laureti S.
Perianal fistulae, Perianal disease, Colorectal cancer
Files: 1
DOP058: Long term avoidance of steroids associated with exclusive enteral nutrition as induction therapy in pediatric crohn’s disease does not increase surgery, hospitalizations or biologics use: results of a propensity score-matched cohort analys
Year: 2016
Source: ECCO'16 DOP
Authors: Van Limbergen J.
IBD, Crohn's Disease, paediatrics, nutrition
Files: 1
DOP059: Combined anticytokine and local mesenchymal stem cells therapy promotes longer healing of simple fistulas in patients with Crohn's Disease
Year: 2018
Source: ECCO'18 Vienna
Authors: Kagramanova Anna
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP059: Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn’s Disease with Complications or Failure of Medical Treatment
Year: 2016
Source: ECCO'16 DOP
Authors: Gao X.
exclusive enteral nutrition, abscess
Files: 1
DOP059: New human gut xenograft mouse model for intestinal fistulas
Year: 2017
Source: ECCO'17 Barcelona
Authors: Bruckner R.
Perianal fistulae, Enteroenteric fistula, Immunology, Mouse Model
Files: 1
DOP05: Adipose-derived stem cells from Crohn’s disease patients show antigen presenting cell-like properties
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Carolina Serena
Created: Tuesday, 28 May 2019, 3:32 PM
Microbiota, Crohn’s disease, Cell-based therapies, Immunology, Mesenchymal cell, Inflammosomes
Files: 1
DOP05: Perioperative Dietary Therapy in Inflammatory Bowel Disease
Year: 2020
Source: ECCO'20 Vienna
Authors: Michel Adamina
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP060: Real-world treatment pathway visualizations show low use of biologic therapies in Crohn’s Disease and Ulcerative Colitis in the United States
Year: 2017
Source: ECCO'17 Barcelona
Authors: Siegel C.
Anti-TNF agents, Corticosteriods, Patient choice, Thiopurines (AZA / MP)
Files: 1
DOP061: Human amnion epithelial cells reduce intestinal inflammation in a 2,4,6-trinitrobenzene sulfonic acid induced model of Acute Colitis
Year: 2018
Source: ECCO'18 Vienna
Authors: Kuk Nathan
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP062: Biosimilar infliximab (CT-P13) is not inferior to originator infliximab: Explorative IBD subgroup-analyses in Crohn’s Disease and ulcerative colitis from the NOR-SWITCH trial
Year: 2017
Source: ECCO'17 Barcelona
Authors: Jørgensen K.
Crohn's disease, Ulcerative colitis, Infliximab, Biosimilars
Files: 1
DOP062: Malignancy and mortality in paediatric onset inflammatory bowel disease
Year: 2016
Source: ECCO'16 DOP
Authors: Joosse M.
IBD-associated cancer, mortality
Files: 1
DOP062: The anti-MAdCAM antibody SHP647 in Crohn’s Disease: Endoscopic effects of induction therapy
Year: 2018
Source: ECCO'18 Vienna
Authors: D´Haens Geert R
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP063: Measurement of Endoscopic Severity in a Crohn's Disease Multi-Centre Pediatric Inception Cohort: Poor correlation of SES-CD with PCDAI
Year: 2016
Source: ECCO'16 DOP
Authors: Carman N.
disease activity indices, Crohn's Disease
Files: 1
DOP063: Serial tuberculin skin test improves the detection of latent tuberculosis infection in Inflammatory Bowel Disease patients
Year: 2017
Source: ECCO'17 Barcelona
Authors: Taxonera C.
Crohn's disease, Ulcerative colitis, Anti-TNF agents, Thiopurines (AZA / MP), Tuberculosis
Files: 1
DOP064: Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab
Year: 2016
Source: ECCO'16 DOP
Authors: Ungar B.
anti-TNF agents, therapeutic drug monitoring
Files: 1